HIV/AIDS Therapy
LC/MS/MS assay suitable for measuring atazanavir levels in peripheral blood
Published in Blood Weekly, December 4th, 2003
According to published research from the United States, "A selective, accurate, and reproducible LC/MS/MS assay was developed and validated for the determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC) samples."
"In addition to the details of the validated LC/MS/MS method, a practical procedure is described in great detail for the preparation of large supplies of control (blank) PBMC from units of blood (each unit of blood is about...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-12-04)
More Articles from Blood Weekly
- Stem-Cell Transplantation
Allogeneic RIST could be outpatient procedure - Transfusion Medicine
Granulocyte transfusions effective against drug-resistant infection in neutropenic patient - Lymphoma Therapy
Involved field radiation therapy raises TRM risk in stem-cell transplant recipients - Stem-Cell Research
Key components of hematopoietic stem cell niche identified - Stem-Cell Transplantation
CXCR4 antagonist mobilizes CD34+ cells - Stem-Cell Transplantation
Natural killer cell chimerism may mark children with high graft rejection risk - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
